investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Manoj Menon

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Improve clinical care outcomes via phase1/2 study that is evaluating the use of Brentuximab Vedontin in combination with chemotherapy.

Related projects